+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cell Reprogramming"

From
From
From
From
From
From
Cell Dissociation - Global Strategic Business Report - Product Thumbnail Image

Cell Dissociation - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
Transfection Technologies Market Report 2025 - Product Thumbnail Image

Transfection Technologies Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Induced Pluripotent Stem Cells Production Market 2024-2028 - Product Thumbnail Image

Induced Pluripotent Stem Cells Production Market 2024-2028

  • Report
  • May 2024
  • 169 Pages
  • Global
From
From
Emerging Medical Technologies Spotlight - Product Thumbnail Image

Emerging Medical Technologies Spotlight

  • Newsletter
  • April 2025
  • Global
Induced Pluripotent Stem Cells: Global Markets 2023-2028 - Product Thumbnail Image

Induced Pluripotent Stem Cells: Global Markets 2023-2028

  • Report
  • January 2024
  • 121 Pages
  • Global
From
Global Induced Pluripotent Stem Cells Market: 2021-2026 - Product Thumbnail Image

Global Induced Pluripotent Stem Cells Market: 2021-2026

  • Report
  • June 2021
  • 142 Pages
  • Global
From
From
From
Loading Indicator

Cell reprogramming is a biotechnology process that involves the conversion of a cell from one type to another. It is used to create induced pluripotent stem cells (iPSCs) from adult cells, which can then be used to study diseases, develop new treatments, and create personalized medicine. Cell reprogramming is also used to create cell models of diseases, which can be used to study the underlying mechanisms of the disease and develop new therapies. Additionally, cell reprogramming can be used to create cell-based therapies, such as gene therapy, which can be used to treat genetic diseases. Cell reprogramming is a rapidly growing field, with many companies investing in the technology. Some of the companies in the market include Ginkgo Bioworks, Cellular Dynamics International, Fate Therapeutics, and Pluristem Therapeutics. Show Less Read more